174 related articles for article (PubMed ID: 35940591)
1. Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.
Li M; Gao F; Ren X; Dong G; Chen H; Lin AY; Wang DD; Liu M; Lin PP; Shen S; Jiang H; Yang C; Zhang X; Zhao X; Zhu Q; Li M; Cui Y; Lin S
Cancer Sci; 2022 Oct; 113(10):3535-3546. PubMed ID: 35940591
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal detection of subcategorized CD44v6
Wang Y; Zhang L; Tan J; Zhang Z; Liu Y; Hu X; Lu B; Gao Y; Tong L; Liu Z; Zhang H; Lin PP; Li B; Gires O; Zhang T
Cancer Lett; 2023 Sep; 571():216337. PubMed ID: 37553013
[TBL] [Abstract][Full Text] [Related]
3. PD-L1
Zhang L; Zhang X; Liu Y; Zhang T; Wang Z; Gu M; Li Y; Wang DD; Li W; Lin PP
Cancer Lett; 2020 Jan; 469():355-366. PubMed ID: 31678168
[TBL] [Abstract][Full Text] [Related]
4. Combined detection of aneuploid circulating tumor-derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non-small-cell lung cancer.
Lei Y; Sun N; Zhang G; Liu C; Lu Z; Huang J; Zhang C; Zang R; Che Y; Mao S; Fang L; Wang X; Zheng S; He J
Clin Transl Med; 2020 Jul; 10(3):e128. PubMed ID: 32659050
[TBL] [Abstract][Full Text] [Related]
5. Role of aneuploid circulating tumor cells and CD31
Zhang T; Zhang L; Gao Y; Wang Y; Liu Y; Zhang H; Wang Q; Hu F; Li J; Tan J; Wang DD; Gires O; Lin PP; Li B
Mol Oncol; 2021 Nov; 15(11):2891-2909. PubMed ID: 34455700
[TBL] [Abstract][Full Text] [Related]
6. Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer.
Zhang J; Hong Y; Wang L; Hu W; Tian G; Wu D; Wang Y; Dai L; Zhang Z; Yang Y; Fang J
Front Oncol; 2023; 13():829054. PubMed ID: 37213309
[TBL] [Abstract][Full Text] [Related]
7. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer.
Cheng H; Wang S; Luan W; Ye X; Dou S; Tang Z; Zhu H; Lin PP; Li Y; Cui H; Chang X
Chin J Cancer Res; 2021 Apr; 33(2):256-270. PubMed ID: 34158744
[TBL] [Abstract][Full Text] [Related]
8. Case report: Post-therapeutic laryngeal carcinoma patient possessing a high ratio of aneuploid CTECs to CTCs rapidly developed
Mi J; Yang F; Liu J; Liu M; Lin AY; Wang DD; Lin PP; Zeng Q
Front Oncol; 2022; 12():981907. PubMed ID: 36172149
[TBL] [Abstract][Full Text] [Related]
9. Identification and Comprehensive Co-Detection of Necrotic and Viable Aneuploid Cancer Cells in Peripheral Blood.
Lin AY; Wang DD; Li L; Lin PP
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680256
[TBL] [Abstract][Full Text] [Related]
10. Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis.
Lin PP
Cells; 2020 Jun; 9(6):. PubMed ID: 32599893
[TBL] [Abstract][Full Text] [Related]
11. A comparative study on ctDNA and tumor DNA mutations in lung cancer and benign cases with a high number of CTCs and CTECs.
Xie J; Hu B; Gong Y; He S; Lin J; Huang Q; Cheng J
J Transl Med; 2023 Dec; 21(1):873. PubMed ID: 38041139
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells (CTCs)/circulating tumor endothelial cells (CTECs) and their subtypes in small cell lung cancer: Predictors for response and prognosis.
Zhu HH; Liu YT; Feng Y; Zhang LN; Zhang TM; Dong GL; Xing PY; Wang HY; Shi YK; Hu XS
Thorac Cancer; 2021 Oct; 12(20):2749-2757. PubMed ID: 34423906
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor-Derived Endothelial Cells: An Effective Biomarker for Breast Cancer Screening and Prognosis Prediction.
Han T; Zhang J; Xiao D; Yang B; Chen L; Zhai C; Ding F; Xu Y; Zhao X; Zhao J
J Oncol; 2022; 2022():5247423. PubMed ID: 36072971
[TBL] [Abstract][Full Text] [Related]
14. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Ge F; Zhang H; Wang DD; Li L; Lin PP
Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.
Lin PP; Gires O; Wang DD; Li L; Wang H
Sci Rep; 2017 Aug; 7(1):9789. PubMed ID: 28852197
[TBL] [Abstract][Full Text] [Related]
16. [Identification of circulating tumor cells in peripheral blood for gliomas by detection of aneuploid cells].
Li MX; Ren XH; Jiang HH; Yang KY; Lin S; Cui Y
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1184-1188. PubMed ID: 31006224
[No Abstract] [Full Text] [Related]
17. Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.
Luo S; Ou Y; Zheng T; Jiang H; Wu Y; Zhao J; Zhang Z
J Oncol; 2021; 2021():1517488. PubMed ID: 34976053
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary Expression of HER2 Conferred by Chromosome Aneuploidy on Circulating Gastric Cancer Cells Contributes to Developing Targeted and Chemotherapeutic Resistance.
Li Y; Zhang X; Liu D; Gong J; Wang DD; Li S; Peng Z; Li Y; Wang X; Lin PP; Li M; Shen L
Clin Cancer Res; 2018 Nov; 24(21):5261-5271. PubMed ID: 30012565
[No Abstract] [Full Text] [Related]
19. A comparison of two methods for the detection of circulating tumour cells in patients with oral cavity cancer.
Curtin J; Wong G; Wang W; Thomson P; Lam AK; Choi SW
J Oral Pathol Med; 2022 Mar; 51(3):249-255. PubMed ID: 34586677
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
